5 Nov 2018

Find out why LSNE is a rare asset in the Healthcare industry

Biological drugs are the newest wave of exciting drugs that are being developed and LSNE is a rare asset in that industry. The business provides innovative lyophilisation solutions to the pharma, healthcare & biotech industries. Backing LSNE capitalises on two of our healthcare team’s core themes: healthcare outsourcing and complexity in niche markets. Find out how we are supporting its innovation and expansion.

Related Investments